Evidence map›Paper›PMID 36052462›Full record

Trial reportJournal of the International AIDS Society2022

Monitoring adherence to antiretroviral therapy among adolescents in Southern Uganda: comparing Wisepill to Self-report in predicting viral suppression in a cluster-randomized trial.

Samuel Kizito, Flavia Namuwonge, Rachel Brathwaite, Torsten B Neilands, Proscovia Nabunya, Ozge Sensoy Bahar, Christopher Damulira, Abel Mwebembezi, Claude Mellins, Mary M McKay and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International AIDS Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Samuel KizitoInternational Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, Missouri, USA.
Flavia NamuwongeInternational Center for Child Health and Development, Masaka, Uganda.
Rachel BrathwaiteInternational Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, Missouri, USA.
Torsten B NeilandsDivision of Prevention Science, University of California, San Francisco, California, USA.
Proscovia NabunyaInternational Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, Missouri, USA.
Ozge Sensoy BaharInternational Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, Missouri, USA.
Christopher DamuliraInternational Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, Missouri, USA.
Abel MwebembeziReach the Youth Uganda, Kampala, Uganda.
Claude MellinsColumbia University, HIV Center for Clinical and Behavioral Studies, Department of Psychiatry, New York State Psychiatric Institute and Columbia University, New York City, New York, USA.
Mary M McKayInternational Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, Missouri, USA.
Fred M SsewamalaInternational Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, Missouri, USA.
Washington University in St. Louis · USColumbia University · USMasaka Hospital · UGMinistry of Education, Science, Technology and Sports · UGUniversity of California, San Francisco · US

Funding

Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
Suubi+Adherence-R2: Examining the longitudinal HIV treatment adherence among youth living with HIV (YLHIV) transitioning into young adulthoodR01HD074949 · NICHD · WASHINGTON UNIVERSITY · PI NABUNYA, PROSCOVIA, SENSOY BAHAR, OZGE · 2012 to 2024
$7.7M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
Strengthening Child Health Research Capacity in Resource Constrained Settings: Researcher Resilience Training (RRT)R25MH118935 · NIMH · WASHINGTON UNIVERSITY · PI SEAN JOE, Mary McKernan McKay · 2018 to 2026
$1.5M
NICHD NIH HHS R01 HD074949NIMH NIH HHS P30 MH062246NIMH NIH HHS R25 MH067127NIMH NIH HHS R25 MH118935
6 · The paper itself

Abstract

introductionOptimal antiretroviral therapy (ART) adherence is crucial for improved patient outcomes; however, ART adherence among adolescents living with HIV (ALHIV) is low. Also, the performance of various adherence measures among ALHIV is under contention. We monitored ART adherence and compared Self-report (SR) and Wisepill electronic monitoring (EM) performance in measuring ART adherence and predicting HIV viral suppression among ALHIV.

methodsBetween January 2014 and December 2015, we recruited 702 ALHIV aged 10-16 years into our cluster-randomized controlled trial (2012-2018) in 39 clinics in Uganda. The intervention included a long-term savings child development account, four micro-enterprise workshops and 12 mentorship sessions. Using the entire sample, we performed multilevel logistic regression to predict monthly ART adherence trends for the first year of follow-up. Since it is possible that the intervention had different effects on SR and EM adherence, we used participants in the control arm only to compare adherence using SR and EM and to calculate their sensitivity and specificity in predicting viral suppression.

resultsThere was a significant decline in adherence for each month throughout the entire follow-up period regardless of the group assigned. Good ART adherence was measured at 79.2% (75.2-82.6%) and 97.0% (95.4-98.1%) using EM and SR, respectively. Overall, 64.3% (60.6-67.9%) had suppressed viral loads. The specificities for EM and SR in predicting viral non-suppression were 80.4% (73.6-85.7%) and 96.7% (93.3-98.4%), while the sensitivities were 22.9% (15.0-33.3%) and 1.8% (0.4-6.9%), respectively. The area under the curve was low for both EM and SR, at 53.6% (45.7-61.5%) and 56.2% (53.2-59.3%), respectively. There was high agreement (78%) between SR and EM in monitoring adherence.

conclusionsOur findings highlighted the need for strategies for sustained optimal adherence. SR and EM measure adherence with a considerable agreement; however, neither is an accurate predictor of virological outcome. There is still a need for an acceptable, feasible and affordable method that predicts viral suppression among ALHIV.

Indexed as

Anti-HIV AgentsHIV InfectionsAdolescentAnti-Retroviral AgentsChildHumansMedication AdherenceSelf ReportUgandaViral LoadAnti-HIV AgentsAnti-Retroviral AgentsadolescentsART adherenceeconomic empowermentHIV/AIDSreal-time monitoringsub-Saharan Africa

Identifiers

PMID36052462
PMCPMC9437555
OpenAlexW4294193012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.